URIST MARSHALL (EVP & Co-Head Research & Inv.) sold 42.9% of their position (13.68K shares) of ROYALTY PHARMA PLC on the open market
Open‑market sale worth $721.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/22/2026ACC: 0001838139-26-000018
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
-13.68K
Net shares
Net seller
$721.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
13.68K disposed
Non-Derivative Transactions1
Class A Ordinary Shares
Direct
Shares
−13.68K
Price / share
$52.75
Trade value
$721.84K
% of position
42.9%
5/20/2026
31.88K→18.20K
Total
Net shares
−13.68K
Net value
-$721.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares Direct | 5/20/2026 | S · Sale | −13.68K | $52.75 | $721.84K | 42.9% | 31.88K | 18.20K |
| Total | −13.68K | -$721.84K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Ordinary Shares
IndirectShares owned19.02K
Total
19.02K indirect19.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Ordinary Shares | 19.02K | Indirect |
| Total | 19.02K | 19.02K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported